In vitro test for the evaluation of the efficacy of topical products for the control of Cochliomyia hominivorax larvae
Authors:
- Ricardo de Andrade FurtadoRFRicardo de Andrade Furtado
- Daniel Paulino JúniorDJDaniel Paulino Júnior
- Maria Cecília SoaresMSMaria Cecília Soares
- Lorena Lopes FerreiraLFLorena Lopes Ferreira
- Vando Edésio SoaresVSVando Edésio Soares
- Welber Daniel Zanetti LopesWLWelber Daniel Zanetti Lopes
- Rafael Paranhos de MendonçaRMRafael Paranhos de Mendonça
Open Access
- 1 April 2020
- journal article
- research article
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 147 (7) , 816-821
Abstract
Cochliomyia hominivorax larvae cause myiasis in animals and humans. To register a commercial product to control this dipteran is necessary to experiment on animals. The in vitro test was standardized to evaluate the larvicidal efficacy of commercial topical products. Five formulations were analysed in vitro and in vivo. For the in vitro test, a colony was formed and three replicates (n = 200) of each larval stage (L1, L2 and L3) were treated. The viability of the larvae was evaluated after 5 and 30 min, and at 1, 2, 6, 12, 24, 48, 60 and 72 h post-treatment (HPT). For the in vivo test, 30 bovines divided into six groups were castrated to achieve natural infestation with C. hominivorax. Animals in the treated groups received the product. Myiasis and efficacy were evaluated 12, 24, 36, 48, 60 and 72 HPT. Four formulations tested in the in vitro test achieved 100% efficacy at 24 HPT. In the in vivo experiment only one achieved 100% efficacy at 24 HPT. However, all products achieved the maximum efficacy by the end of study. The in vitro test developed here could be adopted to evaluate the efficacy of topical products for the control of C. hominivorax larvae.Keywords
This publication has 14 references indexed in Scilit:
- Pain and Bloody Ear Discharge in a Returning TravelerThe American Journal of Tropical Medicine and Hygiene, 2015
- A comparison of three different methodologies for evaluating Rhipicephalus (Boophilus) microplus susceptibility to topical spray compoundsVeterinary Parasitology, 2015
- First report of fluazuron resistance in Rhipicephalus microplus: A field tick population resistant to six classes of acaricidesVeterinary Parasitology, 2014
- Ivermectina e abamectina em diferentes doses e vias de aplicação contra larvas de Cochliomyia hominivorax em bolsas escrotais de bovinos recém-castrados, provenientes da região sudeste do BrasilCiência Rural, 2013
- Should licking behavior be considered in the bioavailability evaluation of transdermal products?Journal of Veterinary Pharmacology and Therapeutics, 2012
- Applicability of in vitro bioassays for the diagnosis of ivermectin resistance in Rhipicephalus microplus (Acari: Ixodidae)Veterinary Parasitology, 2012
- Determination of the susceptibility of Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) to ivermectin and fipronil by Larval Immersion Test (LIT) in UruguayVeterinary Parasitology, 2011
- Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) resistance to fipronil in Uruguay evaluated by in vitro bioassaysVeterinary Parasitology, 2010
- Larval immersion tests with ivermectin in populations of the cattle tick Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) from State of Sao Paulo, BrazilVeterinary Parasitology, 2006
- World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of ectoparasiticides against biting and nuisance flies on ruminantsVeterinary Parasitology, 2006